BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 15957974)

  • 1. Voriconazole: review of a broad spectrum triazole antifungal agent.
    Kofla G; Ruhnke M
    Expert Opin Pharmacother; 2005 Jun; 6(7):1215-29. PubMed ID: 15957974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.
    Maschmeyer G; Haas A
    Future Microbiol; 2006 Dec; 1(4):365-85. PubMed ID: 17661629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.
    Aperis G; Mylonakis E
    Expert Opin Investig Drugs; 2006 Jun; 15(6):579-602. PubMed ID: 16732713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
    Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG
    Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voriconazole : a review of its use in the management of invasive fungal infections.
    Scott LJ; Simpson D
    Drugs; 2007; 67(2):269-98. PubMed ID: 17284090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New antifungal agents: voriconazole and caspofungin].
    Dupont B
    Arch Pediatr; 2003 Dec; 10 Suppl 5():592s-598s. PubMed ID: 15022787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole: therapeutic review of a new azole antifungal.
    Herbrecht R
    Expert Rev Anti Infect Ther; 2004 Aug; 2(4):485-97. PubMed ID: 15482215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of newer antifungal therapies in clinical practice: what do the data tell us?
    Perfect JR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antifungal agents.
    Gupta AK; Tomas E
    Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole -- better chances for patients with invasive mycoses.
    Ghannoum MA; Kuhn DM
    Eur J Med Res; 2002 May; 7(5):242-56. PubMed ID: 12069915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole for candidosis: an important addition?
    Graybill JR
    Lancet; 2005 Oct 22-28; 366(9495):1413-4. PubMed ID: 16243074
    [No Abstract]   [Full Text] [Related]  

  • 13. New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
    Spanakis EK; Aperis G; Mylonakis E
    Clin Infect Dis; 2006 Oct; 43(8):1060-8. PubMed ID: 16983621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in antifungal chemotherapy.
    Petrikkos G; Skiada A
    Int J Antimicrob Agents; 2007 Aug; 30(2):108-17. PubMed ID: 17524625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain.
    Domínguez-Gil A; Martín I; García Vargas M; Del Castillo A; Díaz S; Sánchez C
    Clin Drug Investig; 2007; 27(3):197-205. PubMed ID: 17305414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update on voriconazole].
    Dtsch Med Wochenschr; 2003 Aug; 128(33):1738. PubMed ID: 12968630
    [No Abstract]   [Full Text] [Related]  

  • 17. [Voriconazole: a new weapon against invasive fungal infections].
    Aoun M
    Rev Med Brux; 2004 Jun; 25(3):166-71. PubMed ID: 15291449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.
    Ullmann AJ
    Curr Med Res Opin; 2003; 19(4):263-71. PubMed ID: 12841918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antifungal drugs and the pediatric cancer patient: current status of clinical development.
    Groll AH; Lehrnbecher T
    Klin Padiatr; 2005; 217(3):158-68. PubMed ID: 15858708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on antifungal therapy.
    Gigolashvili T
    Cancer Pract; 1999; 7(3):157-9. PubMed ID: 10352080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.